[1] ARROYAVE-OSPINA J C, WU Z M, GENG Y N, et al.Role of oxidative stress in the pathogenesis of non-alcoholic fatty liver disease:implications for prevention and therapy[J].Antioxidants, 2021, 10(2):174.
[2] SÁNCHEZ-VALLE V, CHÁVEZ-TAPIA N C, URIBE M, et al.Role of oxidative stress and molecular changes in liver fibrosis:a review[J].Current Medicinal Chemistry, 2012, 19(28):4850-4860.
[3] LI S, TAN H Y, WANG N, et al.The role of oxidative stress and antioxidants in liver diseases[J].International Journal of Molecular Sciences, 2015, 16(11):26087-26124.
[4] LOOMBA R, FRIEDMAN S L, SHULMAN G I.Mechanisms and disease consequences of nonalcoholic fatty liver disease[J].Cell, 2021, 184(10):2537-2564.
[5] ARAB J P, ARRESE M, TRAUNER M.Recent insights into the pathogenesis of nonalcoholic fatty liver disease[J].Annual Review of Pathology:Mechanisms of Disease, 2018, 13:321-350.
[6] MAURICE J, MANOUSOU P.Non-alcoholic fatty liver disease[J].Clinical Medicine Journal, 2018, 18(3):245-250.
[7] BRUNT E M, WONG V W S, NOBILI V, et al.Nonalcoholic fatty liver disease[J].Nature Reviews Disease Primers, 2015, 1:15080.
[8] YOUNOSSI Z M, GOLABI P, DE AVILA L, et al.The global epidemiology of NAFLD and NASH in patients with type 2 diabetes:a systematic review and meta-analysis[J].Journal of Hepatology, 2019, 71(4):793-801.
[9] CHALASANI N, YOUNOSSI Z, LAVINE J E, et al.The diagnosis and management of nonalcoholic fatty liver disease:practice guidance from the American association for the study of liver diseases[J].Hepatology, 2018, 67(1):328-357.
[10] BYRNE C D, TARGHER G.NAFLD:a multisystem disease[J].Journal of Hepatology, 2015, 62(1):S47-S64.
[11] PALMIERI V O, GRATTAGLIANO I, PORTINCASA P, et al.Systemic oxidative alterations are associated with visceral adiposity and liver steatosis in patients with metabolic syndrome[J].The Journal of Nutrition, 2006, 136(12):3022-3026.
[12] LEE J H, FRISO S, CHOI S W.Epigenetic mechanisms underlying the link between non-alcoholic fatty liver diseases and nutrition[J].Nutrients, 2014, 6(8):3303-3325.
[13] ZARKOVIC N.Antioxidants and second messengers of free radicals[J].Antioxidants, 2018, 7(11):158.
[14] ZARKOVIC N.Roles and functions of ROS and RNS in cellular physiology and pathology[J].Cells, 2020, 9(3):767.
[15] HALLIWELL B.Free radicals and antioxidants-
quo vadis?[J].Trends in Pharmacological Sciences, 2011, 32(3):125-130.
[16] VALKO M, LEIBFRITZ D, MONCOL J, et al.Free radicals and antioxidants in normal physiological functions and human disease[J].The International Journal of Biochemistry & Cell Biology, 2007, 39(1):44-84.
[17] ZEESHAN H M A, LEE G H, KIM H R, et al.Endoplasmic reticulum stress and associated ROS[J].International Journal of Molecular Sciences, 2016, 17(3):327.
[18] MA Y A, LEE G, HEO S Y, et al.Oxidative stress is a key modulator in the development of nonalcoholic fatty liver disease[J].Antioxidants, 2021, 11(1):91.
[19] YAN Y, WU X, WANG P C, et al.Homocysteine promotes hepatic steatosis by activating the adipocyte lipolysis in a HIF1α-ERO1α-dependent oxidative stress manner[J].Redox Biology, 2020, 37:101742.
[20] AL-SALEH F, KHASHAB F, FADEL F, et al.Inhibition of NADPH oxidase alleviates germ cell apoptosis and ER stress during testicular ischemia reperfusion injury[J].Saudi Journal of Biological Sciences, 2020, 27(8):2174-2184.
[21] TAO Y, QIU T M, YAO X F, et al.IRE1α/NOX4 signaling pathway mediates ROS-dependent activation of hepatic stellate cells in NaAsO
2-induced liver fibrosis[J].Journal of Cellular Physiology, 2021, 236(2):1469-1480.
[22] MURPHY M P.How mitochondria produce reactive oxygen species[J].Biochemical Journal, 2009, 417(1):1-13.
[23] ARFIN S, JHA N K, JHA S K, et al.Oxidative stress in cancer cell metabolism[J].Antioxidants, 2021, 10(5):642.
[24] KUZNETSOV A V, KEHRER I, KOZLOV A V, et al.Mitochondrial ROS production under cellular stress:comparison of different detection methods[J].Analytical and Bioanalytical Chemistry, 2011, 400(8):2383-2390.
[25] BONEKAMP N A, VÖLKL A, FAHIMI H D, et al.Reactive oxygen species and peroxisomes:struggling for balance[J].BioFactors, 2009, 35(4):346-355.
[26] HE Y A, CHEN X W, TAN M, et al.Acetyl-CoA derived from hepatic peroxisomal β-oxidation inhibits autophagy and promotes steatosis via mTORC1 activation[J].Molecular Cell, 2020, 79(1):30-42.e4.
[27] TRIPATHI D N, WALKER C L.The peroxisome as a cell signaling organelle[J].Current Opinion in Cell Biology, 2016, 39:109-112.
[28] TANG G Y, XU Y, ZHANG C, et al.Green tea and epigallocatechin gallate (EGCG) for the management of nonalcoholic fatty liver diseases (NAFLD):insights into the role of oxidative stress and antioxidant mechanism[J].Antioxidants, 2021, 10(7):1076.
[29] DAY C P, JAMES O F W.Steatohepatitis:a tale of two "hits"?[J].Gastroenterology, 1998, 114(4):842-845.
[30] TILG H, ADOLPH T E, MOSCHEN A R.Multiple parallel hits hypothesis in nonalcoholic fatty liver disease:revisited after a decade[J].Hepatology, 2021, 73(2):833-842.
[31] DONNELLY K L, SMITH C I, SCHWARZENBERG S J, et al.Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease[J].The Journal of Clinical Investigation, 2005, 115(5):1343-1351.
[32] TILG H, MOSCHEN A R.Evolution of inflammation in nonalcoholic fatty liver disease:the multiple parallel hits hypothesis[J].Hepatology, 2010, 52(5):1836-1846.
[33] GIORGIO V, PRONO F, GRAZIANO F, et al.Pediatric non alcoholic fatty liver disease:old and new concepts on development, progression, metabolic insight and potential treatment targets[J].BMC Pediatrics, 2013, 13:40.
[34] ABE Y, HINES I N, ZIBARI G Z, et al.Mouse model of liver ischemia and reperfusion injury:method for studying reactive oxygen and nitrogen metabolites
in vivo[J].Free Radical Biology & Medicine, 2009, 46(1):1-7.
[35] SAEEDI B J, LIU K H, OWENS J A, et al.Gut-resident lactobacilli activate hepatic Nrf2 and protect against oxidative liver injury[J].Cell Metabolism, 2020, 31(5):956-968.e5.
[36] DEBLASI J M, DENICOLA G M.Dissecting the crosstalk between NRF2 signaling and metabolic processes in cancer[J].Cancers, 2020, 12(10):3023.
[37] YAMAMOTO M, KENSLER T W, MOTOHASHI H.The KEAP1-NRF2 system:a thiol-based sensor-effector apparatus for maintaining redox homeostasis[J].Physiological Reviews, 2018, 98(3):1169-1203.
[38] DAYALAN NAIDU S, DINKOVA-KOSTOVA A T.KEAP1, a cysteine-based sensor and a drug target for the prevention and treatment of chronic disease[J].Open Biology, 2020, 10(6):200105.
[39] ITOH K, WAKABAYASHI N, KATOH Y, et al.Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain[J].Genes & Development, 1999, 13(1):76-86.
[40] TONELLI C, CHIO I I C, TUVESON D A.Transcriptional regulation by Nrf2[J].Antioxidants & Redox Signaling, 2018, 29(17):1727-1745.
[41] CANNING P, SORRELL F J, BULLOCK A N.Structural basis of Keap1 interactions with Nrf2[J].Free Radical Biology & Medicine, 2015, 88(Pt B):101-107.
[42] BAIRD L, SWIFT S, LLōRES D, et al.Monitoring Keap1-Nrf2 interactions in single live cells[J].Biotechnology Advances, 2014, 32(6):1133-1144.
[43] LEVONEN A L, LANDAR A, RAMACHANDRAN A, et al.Cellular mechanisms of redox cell signalling:role of cysteine modification in controlling antioxidant defences in response to electrophilic lipid oxidation products[J].Biochemical Journal, 2004, 378(Pt 2):373-382.
[44] ITOH K, TONG K I, YAMAMOTO M.Molecular mechanism activating Nrf2-Keap1 pathway in regulation of adaptive response to electrophiles[J].Free Radical Biology & Medicine, 2004, 36(10):1208-1213.
[45] ZIMTA A A, CENARIU D, IRIMIE A, et al.The role of Nrf2 activity in cancer development and progression[J].Cancers, 2019, 11(11):1755.
[46] JAIN A K, JAISWAL A K.Retraction:phosphorylation of tyrosine 568 controls nuclear export of Nrf2[J].Journal of Biological Chemistry, 2017, 292(5):2051.
[47] MALHOTRA D, PORTALES-CASAMAR E, SINGH A, et al.Global mapping of binding sites for Nrf2 identifies novel targets in cell survival response through ChIP-Seq profiling and network analysis[J].Nucleic Acids Research, 2010, 38(17):5718-5734.
[48] GALICIA-MORENO M, LUCANO-LANDEROS S, MONROY-RAMIREZ H C, et al.Roles of Nrf2 in liver diseases:molecular, pharmacological, and epigenetic aspects[J].Antioxidants, 2020, 9(10):980.
[49] HIGGINS L G, KELLEHER M O, EGGLESTON I M, et al.Transcription factor Nrf2 mediates an adaptive response to sulforaphane that protects fibroblasts
in vitro against the cytotoxic effects of electrophiles, peroxides and redox-cycling agents[J].Toxicology and Applied Pharmacology, 2009, 237(3):267-280.
[50] HAWKES H J K, KARLENIUS T C, TONISSEN K F.Regulation of the human thioredoxin gene promoter and its key substrates:a study of functional and putative regulatory elements[J].Biochimica et Biophysica Acta:General Subjects, 2014, 1840(1):303-314.
[51] HARVEY C J, THIMMULAPPA R K, SINGH A, et al.Nrf2-regulated glutathione recycling independent of biosynthesis is critical for cell survival during oxidative stress[J].Free Radical Biology & Medicine, 2009, 46(4):443-453.
[52] HAYES J D, DINKOVA-KOSTOVA A T.The Nrf2 regulatory network provides an interface between redox and intermediary metabolism[J].Trends in Biochemical Sciences, 2014, 39(4):199-218.
[53] CHEN L, ZHANG Z Y, HOSHINO A, et al.NADPH production by the oxidative pentose-phosphate pathway supports folate metabolism[J].Nature Metabolism, 2019, 1:404-415.
[54] MITSUISHI Y, TAGUCHI K, KAWATANI Y, et al.Nrf2 redirects glucose and glutamine into anabolic pathways in metabolic reprogramming[J].Cancer Cell, 2012, 22(1):66-79.
[55] PETRI S, KÖRNER S, KIAEI M.Nrf2/ARE signaling pathway:key mediator in oxidative stress and potential therapeutic target in ALS[J].Neurology Research International, 2012, 2012:878030.
[56] HE F, RU X L, WEN T.NRF2, a transcription factor for stress response and beyond[J].International Journal of Molecular Sciences, 2020, 21(13):4777.
[57] SHIN S M, YANG J H, KI S H.Role of the Nrf2-ARE pathway in liver diseases[J].Oxidative Medicine and Cellular Longevity, 2013, 2013:763257.
[58] TANAKA Y J, IKEDA T, YAMAMOTO K, et al.Dysregulated expression of fatty acid oxidation enzymes and iron-regulatory genes in livers of Nrf2-null mice[J].Journal of Gastroenterology and Hepatology, 2012, 27(11):1711-1717.
[59] YATES M S, TRAN Q T, DOLAN P M, et al.Genetic versus chemoprotective activation of Nrf2 signaling:overlapping yet distinct gene expression profiles between Keap1 knockout and triterpenoid-treated mice[J].Carcinogenesis, 2009, 30(6):1024-1031.
[60] TANAKA Y J, ALEKSUNES L M, YEAGER R L, et al.NF-E2-related factor 2 inhibits lipid accumulation and oxidative stress in mice fed a high-fat diet[J].The Journal of Pharmacology and Experimental Therapeutics, 2008, 325(2):655-664.
[61] MARUYAMA A, TSUKAMOTO S, NISHIKAWA K, et al.Nrf2 regulates the alternative first exons of CD36 in macrophages through specific antioxidant response elements[J].Archives of Biochemistry and Biophysics, 2008, 477(1):139-145.
[62] ZHANG Y K J, YEAGER R L, TANAKA Y, et al.Enhanced expression of Nrf2 in mice attenuates the fatty liver produced by a methionine-and choline-deficient diet[J].Toxicology and Applied Pharmacology, 2010, 245(3):326-334.
[63] MEAKIN P J, CHOWDHRY S, SHARMA R S, et al.Susceptibility of Nrf2-null mice to steatohepatitis and cirrhosis upon consumption of a high-fat diet is associated with oxidative stress, perturbation of the unfolded protein response, and disturbance in the expression of metabolic enzymes but not with insulin resistance[J].Molecular and Cellular Biology, 2014, 34(17):3305-3320.
[64] TAKAHASHI Y R I, KOBAYASHI Y, KAWATA K, et al.Does hepatic oxidative stress enhance activation of nuclear factor-E2-related factor in patients with nonalcoholic steatohepatitis?[J].Antioxidants & Redox Signaling, 2014, 20(3):538-543.
[65] TANG W, JIANG Y F, PONNUSAMY M, et al.Role of Nrf2 in chronic liver disease[J].World Journal of Gastroenterology, 2014, 20(36):13079-13087.
[66] LIU T, ZHANG L, JOO D, et al.NF-κB signaling in inflammation[J].Signal Transduction and Targeted Therapy, 2017, 2:17023.
[67] OECKINGHAUS A, GHOSH S.The NF-kappaB family of transcription factors and its regulation[J].Cold Spring Harbor Perspectives in Biology, 2009, 1(4):a000034.
[68] SUN S C, CHANG J H, JIN J.Regulation of nuclear factor-κB in autoimmunity[J].Trends in Immunology, 2013, 34(6):282-289.
[69] SMALE S T.Dimer-specific regulatory mechanisms within the NF-κB family of transcription factors[J].Immunological Reviews, 2012, 246(1):193-204.
[70] HAYDEN M S, GHOSH S.NF-κB in immunobiology[J].Cell Research, 2011, 21(2):223-244.
[71] ZHANG J X, WANG X L, VIKASH V, et al.ROS and ROS-mediated cellular signaling[J].Oxidative Medicine and Cellular Longevity, 2016, 2016:4350965.
[72] OLIVEIRA-MARQUES V, MARINHO H S, CYRNE L, et al.Role of hydrogen peroxide in NF-kappaB activation:from inducer to modulator[J].Antioxidants & Redox Signaling, 2009, 11(9):2223-2243.
[73] MORGAN M J, LIU Z.Crosstalk of reactive oxygen species and NF-κB signaling[J].Cell Research, 2011, 21(1):103-115.
[74] GAO W, GUO L, YANG Y, et al.Dissecting the crosstalk between Nrf2 and NF-κB response pathways in drug-induced toxicity[J].Frontiers in Cell and Developmental Biology, 2021, 9:809952.
[75] JIN W, WANG H D, YAN W, et al.Disruption of Nrf2 enhances upregulation of nuclear factor-kappaB activity, proinflammatory cytokines, and intercellular adhesion molecule-1 in the brain after traumatic brain injury[J].Mediators of Inflammation, 2008, 2008:725174.
[76] ZHANG D M, GUO Z X, ZHAO Y L, et al.
L-carnitine regulated Nrf2/Keap1 activation
in vitro and
in vivo and protected oxidized fish oil-induced inflammation response by inhibiting the NF-κB signaling pathway in
Rhynchocypris lagowski Dybowski[J].Fish & Shellfish Immunology, 2019, 93:1100-1110.
[77] SONG J K, ZHANG W, WANG J H, et al.Activation of Nrf2 signaling by salvianolic acid C attenuates NF-κB mediated inflammatory response both
in vivo and
in vitro[J].International Immunopharmacology, 2018, 63:299-310.
[78] LIU F, FENG M, XING J L, et al.Timosaponin alleviates oxidative stress in rats with high fat diet-induced obesity via activating Nrf2/HO-1 and inhibiting the NF-κB pathway[J].European Journal of Pharmacology, 2021, 909:174377.
[79] PEI K, GUI T, KAN D F, et al.An overview of lipid metabolism and nonalcoholic fatty liver disease[J].BioMed Research International, 2020, 2020:4020249.
[80] SAVIC D, HODSON L, NEUBAUER S, et al.The importance of the fatty acid transporter
L-carnitine in non-alcoholic fatty liver disease (NAFLD)[J].Nutrients, 2020, 12(8):2178.
[81] XIA Y Q, LI Q, ZHONG W Z, et al.
L-carnitine ameliorated fatty liver in high-calorie diet/STZ-induced type 2 diabetic mice by improving mitochondrial function[J].Diabetology & Metabolic Syndrome, 2011, 3:31.
[82] DAY E A, FORD R J, STEINBERG G R.AMPK as a therapeutic target for treating metabolic diseases[J].Trends in Endocrinology & Metabolism, 2017, 28(8):545-560.
[83] LI X W, HUANG W K, GU J M, et al.SREBP-1c overactivates ROS-mediated hepatic NF-κB inflammatory pathway in dairy cows with fatty liver[J].Cellular Signalling, 2015, 27(10):2099-2109.
[84] POTTS-KANT E N, LI Z W, TIGHE R M, et al.NAD(P)H:quinone oxidoreductase 1 protects lungs from oxidant-induced emphysema in mice[J].Free Radical Biology and Medicine, 2012, 52(3):705-715.
[85] BARRERA G, PIZZIMENTI S, DAGA M, et al.Lipid peroxidation-derived aldehydes, 4-hydroxynonenal and malondialdehyde in aging-related disorders[J].Antioxidants, 2018, 7(8):102.
[86] PORTER N A.A perspective on free radical autoxidation:the physical organic chemistry of polyunsaturated fatty acid and sterol peroxidation[J].The Journal of Organic Chemistry, 2013, 78(8):3511-3524.
[87] MAGEE N, ZOU A, ZHANG Y X.Pathogenesis of nonalcoholic steatohepatitis:interactions between liver parenchymal and nonparenchymal cells[J].BioMed Research International, 2016, 2016:5170402.
[88] HERNÁNDEZ A, REYES D, GENG Y N, et al.Extracellular vesicles derived from fat-laden hepatocytes undergoing chemical hypoxia promote a pro-fibrotic phenotype in hepatic stellate cells[J].Biochimica et Biophysica Acta:Molecular Basis of Disease, 2020, 1866(10):165857.
[89] 李胜利, 郝阳毅, 王蔚, 等.围产期奶牛糖脂代谢与健康养殖研究进展[J].动物营养学报, 2020, 32(10):4708-4715. LI S L, HAO Y Y, WANG W, et al.Research progress on glucose-lipid metabolism and healthy feeding in transition dairy cows[J].Chinese Journal of Animal Nutrition, 2020, 32(10):4708-4715.(in Chinese)
[90] 李泳欣, 邹艺轩, 刘建新, 等.奶牛氧化应激及天然植物抗氧化提取物研究进展[J].浙江大学学报(农业与生命科学版), 2018, 44(5):549-554. LI Y X, ZOU Y X, LIU J X, et al.Research progress of oxidative stress and natural plant antioxidant extracts in dairy cows[J].Journal of Zhejiang University (Agriculture and Life Sciences), 2018, 44(5):549-554.(in Chinese)
[91] 孙菲菲.胆碱和蛋氨酸对奶牛围产期营养平衡和机体健康的影响及机制[D].博士学位论文.杨凌:西北农林科技大学, 2017. SUN F F.Choline and methionine regulate nutrient balance and health of transition dairy cows:responses and potential mechnisms[D].Ph.D. Thesis.Yangling:Northwest A and F University, 2017.(in Chinese)
[92] 宋玉祥.非酯化脂肪酸激活p38MAPK信号通路诱导体外培养的奶牛肝细胞凋亡[D].硕士学位论文.长春:吉林大学, 2014. SONG Y X.Non-esterified fatty acids activate the p38MAPK signaling pathway to induce bovine hepatocyte apoptosis
in vitro[D].Master's Theses.Changchun:Jilin University, 2014.(in Chinese)
[93] 马向明, 杨在宾, 杨维仁, 等.日粮中添加不同水平维生素A对肉牛机体抗氧化能力的影响[J].动物营养学报, 2005, 17(4):31-35. MA X M, YANG Z B, YANG W R, et al.Effects of dietary supplementation of vitamin A on antioxidant capacity of beef cattle[J].Chinese Journal of Animal Nutrition, 2005, 17(4):31-35.(in Chinese)
[94] 朱勇.微生物源性抗氧化剂对动物机体自由基代谢、肝脏损伤修复及生产性能的影响[D].硕士学位论文.上海:上海交通大学, 2007. ZHU Y.Effects of antioxidant from microbe on free radical metabolic, liver damage repairs and produce performance of animals[D].Master's Thesis.Shanghai:Shanghai Jiaotong University, 2007.(in Chinese)
[95] IPSEN D H, TVEDEN-NYBORG P, LYKKESFELDT J.Does vitamin C deficiency promote fatty liver disease development?[J].Nutrients, 2014, 6(12):5473-5499.
[96] NAN Y M, WU W J, FU N, et al.Antioxidants vitamin E and 1-aminobenzotriazole prevent experimental non-alcoholic steatohepatitis in mice[J].Scandinavian Journal of Gastroenterology, 2009, 44(9):1121-1131.
[97] MIYAZAWA T, BURDEOS G C, ITAYA M, et al.Vitamin E:regulatory redox interactions[J].IUBMB Life, 2019, 71(4):430-441.
[98] PERUMPAIL B J, LI A A, JOHN N, et al.The role of vitamin E in the treatment of NAFLD[J].Diseases, 2018, 6(4):86.
[99] RASO G M, ESPOSITO E, IACONO A, et al.Comparative therapeutic effects of metformin and vitamin E in a model of non-alcoholic steatohepatitis in the young rat[J].European Journal of Pharmacology, 2009, 604(1/2/3):125-131.
[100] MISHRA P, PAITAL B, JENA S, et al.Possible activation of NRF2 by vitamin E/curcumin against altered thyroid hormone induced oxidative stress via NF-κB/AKT/mTOR/KEAP1 signalling in rat heart[J].Scientific Reports, 2019, 9(1):7408.
[101] FANG J, YIN H, YANG Z Z, et al.Vitamin E protects against cadmium-induced sub-chronic liver injury associated with the inhibition of oxidative stress and activation of Nrf2 pathway[J].Ecotoxicology and Environmental Safety, 2021, 208:111610.
[102] HE W X, XU Y J, REN X H, et al.Vitamin E ameliorates lipid metabolism in mice with nonalcoholic fatty liver disease via Nrf2/CES1 signaling pathway[J].Digestive Diseases and Sciences, 2019, 64(11):3182-3191.
[103] VALDECANTOS M P, PÉREZ-MATUTE P, QUINTERO P, et al.Vitamin C, resveratrol and lipoic acid actions on isolated rat liver mitochondria:all antioxidants but different[J].Redox Report, 2010, 15(5):207-216.
[104] REZAZADEH A, YAZDANPARAST R, MOLAEI M.Amelioration of diet-induced nonalcoholic steatohepatitis in rats by Mn-salen complexes via reduction of oxidative stress[J].Journal of Biomedical Science, 2012, 19(1):26.
[105] WEI J, LEI G H, FU L, et al.Association between dietary vitamin C intake and non-alcoholic fatty liver disease:a cross-sectional study among middle-aged and older adults[J].PLoS One, 2016, 11(1):e0147985.
[106] VIAL G, DETAILLE D, GUIGAS B.Role of mitochondria in the mechanism (s) of action of metformin[J].Frontiers in Endocrinology, 2019, 10:294.
[107] ZHOU J, MASSEY S, STORY D, et al.Metformin:an old drug with new applications[J].International Journal of Molecular Sciences, 2018, 19(10):2863.
[108] ZHANG Y, MUN S R, LINARES J F, et al.Mechanistic insight into the regulation of SQSTM1/p62[J].Autophagy, 2019, 15(4):735-737.
[109] BRANDT A, HERNÁNDEZ-ARRIAGA A, KEHM R, et al.Metformin attenuates the onset of non-alcoholic fatty liver disease and affects intestinal microbiota and barrier in small intestine[J].Scientific Reports, 2019, 9(1):6668.
[110] ZHANG Y Q, WANG H B, XIAO H.Metformin actions on the liver:protection mechanisms emerging in hepatocytes and immune cells against NASH-related HCC[J].International Journal of Molecular Sciences, 2021, 22(9):5016.
[111] SHISHODIA S.Molecular mechanisms of curcumin action:gene expression[J].BioFactors, 2013, 39(1):37-55.
[112] JIN W L, BOTCHWAY B O A, LIU X H.Curcumin can activate the Nrf2/HO-1 signaling pathway and scavenge free radicals in spinal cord injury treatment[J].Neurorehabilitation and Neural Repair, 2021, 35(7):576-584.
[113] PAN M H, LAI C S, TSAI M L, et al.Chemoprevention of nonalcoholic fatty liver disease by dietary natural compounds[J].Molecular Nutrition & Food Research, 2014, 58(1):147-171.
[114] KUO J J, CHANG H H, TSAI T H, et al.Positive effect of curcumin on inflammation and mitochondrial dysfunction in obese mice with liver steatosis[J].International Journal of Molecular Medicine, 2012, 30(3):673-679.
[115] RAMIREZ-TORTOSA M C, RAMIREZ-TORTOSA C L, MESA M D, et al.Curcumin ameliorates rabbits's steatohepatitis via respiratory chain, oxidative stress, and TNF-α[J].Free Radical Biology and Medicine, 2009, 47(7):924-931.
[116] XIONG Z E, DONG W G, WANG B Y, et al.Curcumin attenuates chronic ethanol-induced liver injury by inhibition of oxidative stress via mitogen-activated protein kinase/nuclear factor E2-related factor 2 pathway in mice[J].Pharmacognosy Magazine, 2015, 11(44):707-715.
[117] AFRIN R, ARUMUGAM S, RAHMAN A, et al.Curcumin ameliorates liver damage and progression of NASH in NASH-HCC mouse model possibly by modulating HMGB1-NF-κB translocation[J].International Immunopharmacology, 2017, 44:174-182.
京公网安备 11010802041926号